{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:55:59Z","timestamp":1791111359550,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":642,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1593\/neo.111810","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:09:03Z","timestamp":1429794543000},"page":"690-IN6","source":"Crossref","is-referenced-by-count":45,"title":["Stromal Cell-Derived Factor 1\u03b1 Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer"],"prefix":"10.1016","volume":"14","author":[{"given":"Colin D.","family":"Weekes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongweon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Arcaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Rubio-Viqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Cusatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Garrett-Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wells A.","family":"Messersmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Winn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.111810_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000658-200209000-00012","article-title":"Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity and mortality","volume":"236","author":"Yeo","year":"2002","journal-title":"Ann Surg"},{"key":"10.1593\/neo.111810_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000478-200105000-00003","article-title":"Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic ductal lesions","volume":"25","author":"Hruban","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1593\/neo.111810_bib3","first-page":"2002","article-title":"Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression","volume":"60","author":"Wilentz","year":"2000","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111810_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1593\/neo.111810_bib5","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1158\/0008-5472.CAN-04-0807","article-title":"Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells","volume":"64","author":"Agbunag","year":"2004","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111810_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(88)90571-5","article-title":"Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes","volume":"53","author":"Almoguera","year":"1988","journal-title":"Cell"},{"key":"10.1593\/neo.111810_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/jsre.2001.6145","article-title":"FRAP-p70s6k signaling is required for pancreatic cancer cell proliferation","volume":"97","author":"Shah","year":"2001","journal-title":"J Surg Res"},{"key":"10.1593\/neo.111810_bib8","first-page":"3581","article-title":"Regulation of cell growth and cyclin D1 expression by constitutively active FRAP-p70s6k pathway in human pancreatic cancer cells","volume":"59","author":"Grewe","year":"1999","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111810_bib9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.molcel.2010.09.026","article-title":"Regulation of the mTOR complex 1 pathway by nutrients, growth factors and stress","volume":"40","author":"Sengupta","year":"2010","journal-title":"Mol Cell"},{"key":"10.1593\/neo.111810_bib10","first-page":"3373","article-title":"p53\/p21CIP1 cooperate in enforcing rapamycin-induced G1 arrest and determine the cellular response to rapamycin","volume":"61","author":"Huang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111810_bib11","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S1097-2765(03)00180-1","article-title":"Sustained activation of the JUNK cascade and rapamycin-induced apoptosis are suppressed by p53\/p21Cip1","volume":"11","author":"Huang","year":"2003","journal-title":"Mol Cell"},{"key":"10.1593\/neo.111810_bib12","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/ijc.21532","article-title":"In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer","volume":"118","author":"Ito","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1593\/neo.111810_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.2008.18.9514","article-title":"Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer","volume":"27","author":"Wolpin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.111810_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/1471-2407-10-368","article-title":"Inhibition of the mammalian target of rapamycin [mTOR] in advanced pancreatic cancer: results of two phase II studies","volume":"10","author":"Javle","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1593\/neo.111810_bib15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bjc.6605819","article-title":"Integrated preclinical and clinical development of mTOR inhibitors in pancreatic cancer","volume":"103","author":"Garrido-Laguna","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1593\/neo.111810_bib16","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/31269","article-title":"Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development","volume":"393","author":"Zou","year":"1998","journal-title":"Nature"},{"key":"10.1593\/neo.111810_bib17","doi-asserted-by":"crossref","first-page":"35760","DOI":"10.1074\/jbc.M508234200","article-title":"The chemokine SDF-1\/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes","volume":"280","author":"Balabanian","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.111810_bib18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"Muller","year":"2001","journal-title":"Nature"},{"key":"10.1593\/neo.111810_bib19","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1158\/0008-5472.CAN-04-3833","article-title":"Blockade of the stromal cell-derived factor-1\/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner","volume":"65","author":"Guleng","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111810_bib20","first-page":"1969","article-title":"Stromal cell-derived factor 1\u03b1 stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinase 1\/2 and Akt","volume":"63","author":"Barbero","year":"2003","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111810_bib21","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1164\/rccm.200301-071OC","article-title":"The stromal derived factor-1\/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases","volume":"167","author":"Philips","year":"2003","journal-title":"Am J Crit Care Med"},{"key":"10.1593\/neo.111810_bib22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1083\/jcb.200304153","article-title":"The stromal derived factor-1\u03b1\/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas","volume":"163","author":"Kayali","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1593\/neo.111810_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MPA.0b013e3181bb2ab7","article-title":"Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways","volume":"39","author":"Shen","year":"2010","journal-title":"Pancreas"},{"key":"10.1593\/neo.111810_bib24","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1055-9965.EPI-10-0405","article-title":"High levels of expression of human stromal cell-derived factor-1 are associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma","volume":"10","author":"Liang","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1593\/neo.111810_bib25","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gut.2007.143941","article-title":"The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia","volume":"57","author":"Thomas","year":"2008","journal-title":"Gut"},{"key":"10.1593\/neo.111810_bib26","first-page":"1159","article-title":"Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease","volume":"16","author":"Wehler","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1593\/neo.111810_bib27","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-06-0113","article-title":"An in vivo platform for translational drug development in pancreatic cancer","volume":"12","author":"Rubio-Viqueira","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.111810_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jso.21957","article-title":"Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma","volume":"104","author":"Gebauer","year":"2011","journal-title":"J Surg Oncol"},{"key":"10.1593\/neo.111810_bib29","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1074\/jbc.M309999200","article-title":"AKT activity determines sensitivity to mammalian target of rapamycin [mTOR] inhibitors by regulating cyclin D1 and c-myc expression","volume":"279","author":"Gera","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.111810_bib30","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Moore","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.111810_bib31","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1158\/0008-5472.CAN-05-2882","article-title":"C-fos assessment as a marker of anti-epidermal growth factor receptor effect","volume":"66","author":"Jimeno","year":"2006","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111810_bib32","doi-asserted-by":"crossref","first-page":"14484","DOI":"10.1073\/pnas.1008256107","article-title":"CXCR4\/YY1 inhibition impairs VEGF network and angiogenesis during malignancy","volume":"107","author":"de Nigris","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.111810_bib33","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.111810_bib34","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1200\/JCO.2006.09.0886","article-title":"Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group","volume":"25","author":"Herrmann","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.111810_bib35","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1200\/JCO.2009.24.2446","article-title":"Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer","volume":"27","author":"Cunningham","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.111810_bib36","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"10.1593\/neo.111810_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.yexcr.2005.04.024","article-title":"Stromal cell-derived factor-1\u03b1 [SDF-1\u03b1\/CXCL12] stimulates ovarian cancer cell growth through the EGF receptor transactivation","volume":"308","author":"Porcile","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1593\/neo.111810_bib38","doi-asserted-by":"crossref","first-page":"22473","DOI":"10.1074\/jbc.M500963200","volume":"280","author":"Phillips","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.111810_bib39","first-page":"200","article-title":"Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling","volume":"62","author":"Chakravarti","year":"2002","journal-title":"Cancer Res"},{"key":"10.1593\/neo.111810_bib40","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"key":"10.1593\/neo.111810_bib41","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"10.1593\/neo.111810_bib42","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1200\/JCO.2009.25.7550","article-title":"Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205","volume":"28","author":"Philip","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.111810_bib43","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1200\/JCO.2010.28.1386","article-title":"Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B [CALGB 80303]","volume":"28","author":"Kindler","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.111810_bib44","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.05.053","article-title":"Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer","volume":"137","author":"Mueller","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1593\/neo.111810_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","article-title":"VEGF-induced adult neovascularization: recruitment, retention and role of accessory cells","volume":"124","author":"Grunewald","year":"2006","journal-title":"Cell"},{"key":"10.1593\/neo.111810_bib46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"10.1593\/neo.111810_bib47","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1245\/s10434-009-0599-x","article-title":"Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1\/CXCR4 axis","volume":"16","author":"Matsusue","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1593\/neo.111810_bib48","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558612800030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558612800030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T07:27:58Z","timestamp":1537687678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558612800030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1476558612800030"],"URL":"https:\/\/doi.org\/10.1593\/neo.111810","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}